• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫压力下的神经胶质瘤逃逸特征和克隆演化。

Glioma escape signature and clonal development under immune pressure.

机构信息

Department of Neurosurgery and.

Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

出版信息

J Clin Invest. 2020 Oct 1;130(10):5257-5271. doi: 10.1172/JCI138760.

DOI:10.1172/JCI138760
PMID:32603315
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7524465/
Abstract

Immunotherapeutic strategies are increasingly important in neuro-oncology, and the elucidation of escape mechanisms that lead to treatment resistance is crucial. We investigated the impact of immune pressure on the clonal dynamics and immune escape signature by comparing glioma growth in immunocompetent versus immunodeficient mice. Glioma-bearing WT and Pd-1-/- mice survived significantly longer than immunodeficient Pfp-/- Rag2-/- mice. While tumors in Pfp-/- Rag2-/- mice were highly polyclonal, immunoedited tumors in WT and Pd-1-/- mice displayed reduced clonality with emergence of immune escape clones. Tumor cells in WT mice were distinguished by an IFN-γ-mediated response signature with upregulation of genes involved in immunosuppression. Tumor-infiltrating stromal cells, which include macrophages/microglia, contributed even more strongly to the immunosuppressive signature than the actual tumor cells. The identified murine immune escape signature was reflected in human patients and correlated with poor survival. In conclusion, immune pressure profoundly shapes the clonal composition and gene regulation in malignant gliomas.

摘要

免疫治疗策略在神经肿瘤学中越来越重要,阐明导致治疗耐药的逃逸机制至关重要。我们通过比较免疫活性与免疫缺陷小鼠中的神经胶质瘤生长,研究了免疫压力对克隆动力学和免疫逃逸特征的影响。与免疫缺陷 Pfp-/- Rag2-/- 小鼠相比,携带神经胶质瘤的 WT 和 Pd-1-/- 小鼠的存活率显著延长。虽然 Pfp-/- Rag2-/- 小鼠中的肿瘤具有高度的多克隆性,但 WT 和 Pd-1-/- 小鼠中的免疫编辑肿瘤显示出克隆性降低,出现免疫逃逸克隆。WT 小鼠中的肿瘤细胞表现出 IFN-γ 介导的反应特征,其中涉及免疫抑制的基因上调。肿瘤浸润性基质细胞(包括巨噬细胞/小胶质细胞)对免疫抑制特征的贡献甚至强于实际的肿瘤细胞。在人类患者中也反映了鉴定出的鼠免疫逃逸特征,并与不良预后相关。总之,免疫压力深刻地影响了恶性神经胶质瘤的克隆组成和基因调控。

相似文献

1
Glioma escape signature and clonal development under immune pressure.免疫压力下的神经胶质瘤逃逸特征和克隆演化。
J Clin Invest. 2020 Oct 1;130(10):5257-5271. doi: 10.1172/JCI138760.
2
Orphan nuclear receptor TLX promotes immunosuppression via its transcriptional activation of PD-L1 in glioma.孤儿核受体 TLX 通过其对胶质瘤中 PD-L1 的转录激活促进免疫抑制。
J Immunother Cancer. 2021 Apr;9(4). doi: 10.1136/jitc-2020-001937.
3
Progression from low- to high-grade in a glioblastoma model reveals the pivotal role of immunoediting.在胶质母细胞瘤模型中,从低级别到高级别的进展揭示了免疫编辑的关键作用。
Cancer Lett. 2019 Feb 1;442:213-221. doi: 10.1016/j.canlet.2018.10.006. Epub 2018 Oct 9.
4
IDH mutant gliomas escape natural killer cell immune surveillance by downregulation of NKG2D ligand expression.异柠檬酸脱氢酶(IDH)突变型胶质瘤通过下调自然杀伤细胞2D型受体(NKG2D)配体的表达来逃避自然杀伤细胞的免疫监视。
Neuro Oncol. 2016 Oct;18(10):1402-12. doi: 10.1093/neuonc/now061. Epub 2016 Apr 25.
5
Endothelin B receptor promotes the proliferation and immune escape of malignant gliomas.内皮素 B 受体促进恶性脑胶质瘤的增殖和免疫逃避。
Artif Cells Nanomed Biotechnol. 2018 Sep;46(6):1230-1235. doi: 10.1080/21691401.2017.1366336. Epub 2017 Aug 25.
6
Deletion of the RNA regulator HuR in tumor-associated microglia and macrophages stimulates anti-tumor immunity and attenuates glioma growth.肿瘤相关小胶质细胞和巨噬细胞中 RNA 调节因子 HuR 的缺失可刺激抗肿瘤免疫并抑制神经胶质瘤生长。
Glia. 2019 Dec;67(12):2424-2439. doi: 10.1002/glia.23696. Epub 2019 Aug 10.
7
[The immunosuppressive microenvironment of malignant gliomas].[恶性胶质瘤的免疫抑制微环境]
Arkh Patol. 2015 Nov-Dec;77(6):54-63. doi: 10.17116/patol201577654-63.
8
Immunosuppressive Myeloid Cells' Blockade in the Glioma Microenvironment Enhances the Efficacy of Immune-Stimulatory Gene Therapy.阻断胶质瘤微环境中的免疫抑制性髓样细胞可增强免疫刺激基因治疗的疗效。
Mol Ther. 2017 Jan 4;25(1):232-248. doi: 10.1016/j.ymthe.2016.10.003.
9
Distinct roles of CSF family cytokines in macrophage infiltration and activation in glioma progression and injury response.脑脊液家族细胞因子在胶质瘤进展和损伤反应中对巨噬细胞浸润和激活的不同作用。
J Pathol. 2013 Jul;230(3):310-21. doi: 10.1002/path.4192.
10
Identification of a five B cell-associated gene prognostic and predictive signature for advanced glioma patients harboring immunosuppressive subtype preference.鉴定一种与五个B细胞相关基因的预后和预测特征,用于具有免疫抑制亚型偏好的晚期胶质瘤患者。
Oncotarget. 2016 Nov 8;7(45):73971-73983. doi: 10.18632/oncotarget.12605.

引用本文的文献

1
Barcoded viral tracing identifies immunosuppressive astrocyte-glioma interactions.条形码病毒示踪法鉴定免疫抑制性星形胶质细胞与胶质瘤的相互作用。
Nature. 2025 Jun 25. doi: 10.1038/s41586-025-09191-9.
2
Atorvastatin inhibits glioma glycolysis and immune escape by modulating the miR-125a-5p/TXLNA axis.阿托伐他汀通过调节miR-125a-5p/TXLNA轴抑制胶质瘤糖酵解和免疫逃逸。
Hereditas. 2024 Dec 26;161(1):54. doi: 10.1186/s41065-024-00349-5.
3
Evolution of myeloid-mediated immunotherapy resistance in prostate cancer.前列腺癌中髓系介导的免疫治疗耐药性的演变
Nature. 2025 Jan;637(8048):1207-1217. doi: 10.1038/s41586-024-08290-3. Epub 2024 Dec 4.
4
Co-evolution of glioma and immune microenvironment.胶质瘤与免疫微环境的共同进化
J Immunother Cancer. 2024 Dec 3;12(12):e009175. doi: 10.1136/jitc-2024-009175.
5
Molecular Spies in Action: Genetically Encoded Fluorescent Biosensors Light up Cellular Signals.分子间谍大显身手:基因编码荧光生物传感器点亮细胞信号。
Chem Rev. 2024 Nov 27;124(22):12573-12660. doi: 10.1021/acs.chemrev.4c00293. Epub 2024 Nov 13.
6
Immunoediting Dynamics in Glioblastoma: Implications for Immunotherapy Approaches.免疫编辑在胶质母细胞瘤中的动态变化:对免疫治疗方法的启示。
Cancer Control. 2024 Jan-Dec;31:10732748241290067. doi: 10.1177/10732748241290067.
7
Alterations in Astrocyte Subpopulations in Glioma and Identification of Cuproptosis-Related Genes Using Single-Cell RNA Sequencing.胶质瘤中星形胶质细胞亚群的改变及利用单细胞RNA测序鉴定铜死亡相关基因
J Inflamm Res. 2024 Sep 11;17:6329-6344. doi: 10.2147/JIR.S473932. eCollection 2024.
8
Immunotherapeutic advances in glioma management: The rise of vaccine-based approaches.免疫治疗在神经胶质瘤治疗管理中的进展:基于疫苗的方法的兴起。
CNS Neurosci Ther. 2024 Sep;30(9):e70013. doi: 10.1111/cns.70013.
9
Remote Neuroinflammation in Newly Diagnosed Glioblastoma Correlates with Unfavorable Clinical Outcome.新诊断的胶质母细胞瘤中的远程神经炎症与不良临床结局相关。
Clin Cancer Res. 2024 Oct 15;30(20):4618-4634. doi: 10.1158/1078-0432.CCR-24-1563.
10
Lymphatic endothelial-like cells promote glioblastoma stem cell growth through cytokine-driven cholesterol metabolism.淋巴内皮样细胞通过细胞因子驱动的胆固醇代谢促进神经胶质瘤干细胞生长。
Nat Cancer. 2024 Jan;5(1):147-166. doi: 10.1038/s43018-023-00658-0. Epub 2024 Jan 3.

本文引用的文献

1
Heterogeneity of response to immune checkpoint blockade in hypermutated experimental gliomas.免疫检查点阻断在高突变实验性脑胶质瘤中的反应异质性。
Nat Commun. 2020 Feb 18;11(1):931. doi: 10.1038/s41467-020-14642-0.
2
Immunologic Profiling of Mutational and Transcriptional Subgroups in Pediatric and Adult High-Grade Gliomas.免疫分析在小儿和成人高级别胶质瘤突变和转录亚群中的作用
Cancer Immunol Res. 2019 Sep;7(9):1401-1411. doi: 10.1158/2326-6066.CIR-18-0939. Epub 2019 Jul 2.
3
Immune checkpoint molecule herpes virus entry mediator is overexpressed and associated with poor prognosis in human glioblastoma.免疫检查点分子疱疹病毒进入介质在人胶质母细胞瘤中过表达,并与不良预后相关。
EBioMedicine. 2019 May;43:159-170. doi: 10.1016/j.ebiom.2019.04.002. Epub 2019 Apr 12.
4
Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma.新辅助抗 PD-1 免疫治疗在复发性胶质母细胞瘤中促进了肿瘤内和全身免疫应答,并带来生存获益。
Nat Med. 2019 Mar;25(3):477-486. doi: 10.1038/s41591-018-0337-7. Epub 2019 Feb 11.
5
Local mutational diversity drives intratumoral immune heterogeneity in non-small cell lung cancer.局部突变多样性驱动非小细胞肺癌肿瘤内免疫异质性。
Nat Commun. 2018 Dec 18;9(1):5361. doi: 10.1038/s41467-018-07767-w.
6
STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets.STRING v11:具有增强覆盖范围的蛋白质-蛋白质相互作用网络,支持在全基因组实验数据集的功能发现。
Nucleic Acids Res. 2019 Jan 8;47(D1):D607-D613. doi: 10.1093/nar/gky1131.
7
The Interferon-Gamma Paradox in Cancer.癌症中的干扰素-γ 悖论。
J Interferon Cytokine Res. 2019 Jan;39(1):30-38. doi: 10.1089/jir.2018.0087. Epub 2018 Nov 9.
8
Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors.在脑胶质瘤和其他颅内肿瘤的情况下,T 细胞在骨髓中的隔离。
Nat Med. 2018 Sep;24(9):1459-1468. doi: 10.1038/s41591-018-0135-2. Epub 2018 Aug 13.
9
Current state of immunotherapy for glioblastoma.胶质母细胞瘤的免疫治疗现状。
Nat Rev Clin Oncol. 2018 Jul;15(7):422-442. doi: 10.1038/s41571-018-0003-5.
10
The Immune Landscape of Cancer.癌症的免疫全景。
Immunity. 2018 Apr 17;48(4):812-830.e14. doi: 10.1016/j.immuni.2018.03.023. Epub 2018 Apr 5.